Finance

Lists
Why is NXTG up 2,84%?
Dive Deeper
NXTG:TLV
Nextage Therapeutics Ltd
39,90 ILA
+2,84%
(+1,10) 1D
5-окт., 10:15:00 GMT+3  ·   ILA
All symbols
SymbolPriceChange% Change
Generating top insights for NXTG...
Open
39,90 ILA
High
39,90 ILA
Low
39,90 ILA
Mkt. cap
37,85 млн
Avg. vol.
62,54 миң
Volume
1,00 миң
52-wk high
77,00 ILA
52-wk low
27,00 ILA
EPS
-0,07 ILA
Shares outstanding
94,86 млн
No. of employees
18
Open
39,90 ILA
High
39,90 ILA
Low
39,90 ILA
Mkt. cap
37,85 млн
Avg. vol.
62,54 миң
Volume
1,00 миң
52-wk high
77,00 ILA
52-wk low
27,00 ILA
EPS
-0,07 ILA
Shares outstanding
94,86 млн
No. of employees
18
News stories
From web sources and news partners
About Nextage Therapeutics Ltd
CEO-
Employees18
Founded1982
Headquarters-
Sector-
Previous reportsAll values in ILS
Loading Previous Earnings...
Revenue
Net income
All values in ILS
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
1,12 млн
1,12 млн
134,00 миң
134,00 миң
Cost of goods sold
894,50 миң
894,50 миң
762,00 миң
762,00 миң
Cost of revenue
894,50 миң
894,50 миң
762,00 миң
762,00 миң
Research and development expenses
770,50 миң
770,50 миң
513,50 миң
513,50 миң
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,17 млн
2,17 млн
2,30 млн
2,30 млн
Operating expense
2,94 млн
2,94 млн
2,81 млн
2,81 млн
Total operating expenses
3,83 млн
3,83 млн
3,57 млн
3,57 млн
Operating income
-2,71 млн
-2,71 млн
-3,44 млн
-3,44 млн
Other non operating income
-694,00 миң
-694,00 миң
-
-
EBT including unusual items
-3,71 млн
-3,71 млн
-4,28 млн
-4,28 млн
EBT excluding unusual items
-3,71 млн
-3,71 млн
-4,28 млн
-4,28 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-3,71 млн
-3,71 млн
-4,21 млн
-4,21 млн
Net profit margin
-330,57%
-330,57%
-3 143,66%
-3 143,66%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-162,50 миң
-162,50 миң
-837,00 миң
-837,00 миң
Net interest expenses
-162,50 миң
-162,50 миң
-837,00 миң
-837,00 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-2,52 млн
-2,59 млн
-3,12 млн
-3,12 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору